Embed Code
The Japanese Medical Marijuana Association (JMMA) stands at the forefront of cannabis advocacy in Japan, focusing on the medicinal benefits of marijuana. Founded amidst a global shift towards recognizing cannabis’s health benefits, the JMMA is committed to promoting research, education, and policy reform. While cannabis has ancient roots in Japan, primarily for spiritual and practical uses, its medical application is a relatively new frontier. The JMMA is instrumental in navigating this transition, advocating for evidence-based approaches and patient access to medical cannabis. By collaborating with international experts and local stakeholders, the Japanese Medical Marijuana Association aims to integrate cannabis into Japan’s healthcare system responsibly and ethically. This organization is pivotal in transforming the landscape of medical marijuana in Japan, ensuring that patients receive the benefits of this ancient plant in a modern medical context. [Source: Japanese Medical Marijuana Association Official Website]
The Japanese Medical Marijuana Association (Japanese: 医療大麻を考える会, Iryō taima o kangaeru kai) was founded in 1999 and seeks to improve access to medical cannabis. Its status under Japanese law is Specified Nonprofit Corporation (特定非営利活動法人).[non-primary source needed] Due to the illegality of cannabis in Japan, the organization has investigated leveraging legal medical cannabis in Guam for Japanese patients.
![]() |
In 2014, JMMA president Koichi Maeda met with Guamanian senator Tina Muna Barnes regarding Guam's medical cannabis program. In 2017, Maeda returned and met with governor Eddie Calvo. Maeda's intent was to develop Guam as a destination for Japanese people seeking cannabis remedies, and for the JMMA to promote cannabis medical tourism to Guam.
Japan's strict laws prevent Japanese citizens from using cannabis even when outside of Japan. However, Maeda stated that Japanese citizens with incurable diseases would be exempt from this law.